| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.588 | 0.009 | 0.614 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.614 0.005 CID_356023 | CID_356023 | |
| 0.521 | 0.021 | 0.521 | GABA C receptor rho-3 antagonist | 0.321 0.103 CID_356023 | ||
| 0.452 | 0.004 | 0.452 | Topoisomerase I inhibitor | 0.363 0.007 CID_356023 | ||
| 0.419 | 0.048 | 0.419 | MAP kinase kinase 6 inhibitor | 0.312 0.124 CID_356023 | ||
| 0.393 | 0.023 | 0.393 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.335 0.043 CID_356023 | ||
| 0.377 | 0.019 | 0.377 | ErbB-1 antagonist | 0.277 0.04 CID_356023 | ||
| 0.364 | 0.025 | 0.401 | Interleukin agonist | 0.401 0.019 CID_356023 | CID_356023 | |
| 0.357 | 0.046 | 0.357 | Aryl hydrocarbon receptor agonist | 0.327 0.054 CID_356023 | ||
| 0.32 | 0.01 | 0.32 | Toll-Like receptor 9 antagonist | 0.198 0.036 CID_356023 | ||
| 0.308 | 0.011 | 0.308 | DNA intercalator | 0.232 0.019 CID_356023 | ||
| 0.322 | 0.028 | 0.322 | MAP kinase kinase 2 inhibitor | 0.22 0.07 CID_356023 | ||
| 0.323 | 0.036 | 0.323 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.186 0.084 CID_356023 | ||
| 0.287 | 0.01 | 0.287 | MAP kinase kinase 3 inhibitor | 0.219 0.076 CID_356023 | ||
| 0.326 | 0.057 | 0.348 | Interleukin 2 agonist | 0.348 0.046 CID_356023 | CID_356023 | |
| 0.36 | 0.095 | 0.434 | Histamine release inhibitor | 0.434 0.058 CID_356023 | CID_356023 | |
| 0.3 | 0.044 | 0.3 | DNA synthesis inhibitor | 0.201 0.122 CID_356023 | ||
| 0.318 | 0.073 | 0.318 | Immunomodulator | 0.246 0.118 CID_356023 | ||
| 0.283 | 0.041 | 0.283 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.189 0.085 CID_356023 | ||
| 0.297 | 0.058 | 0.297 | DNA damaging | 0.213 0.105 CID_356023 | ||
| 0.239 | 0.005 | 0.239 | Antineoplastic alkaloid | 0.221 0.009 CID_356023 | ||
| 0.245 | 0.018 | 0.271 | Hexokinase inhibitor | 0.271 0.014 CID_356023 | CID_356023 | |
| 0.278 | 0.051 | 0.278 | Cyclic AMP phosphodiesterase inhibitor | 0.209 0.087 CID_356023 | ||
| 0.253 | 0.03 | 0.253 | Tumour necrosis factor antagonist | 0.14 0.113 CID_356023 | ||
| 0.268 | 0.05 | 0.268 | Anticonvulsant | 0.141 0.14 CID_356023 | ||
| 0.277 | 0.063 | 0.277 | Tumour necrosis factor alpha release inhibitor | 0.253 0.074 CID_356023 | ||
| 0.234 | 0.027 | 0.234 | Interleukin 6 antagonist | 0.131 0.122 CID_356023 | ||
| 0.218 | 0.012 | 0.218 | Beta amyloid protein antagonist | 0.125 0.063 CID_356023 | ||
| 0.242 | 0.042 | 0.242 | Focal adhesion kinase 2 inhibitor | 0.203 0.067 CID_356023 | ||
| 0.242 | 0.042 | 0.242 | I kappa B kinase epsilon inhibitor | 0.151 0.118 CID_356023 | ||
| 0.217 | 0.025 | 0.217 | Toll-Like receptor antagonist | 0.12 0.084 CID_356023 | ||
| 0.218 | 0.027 | 0.218 | Glycogen synthase kinase-3 inhibitor | 0.146 0.047 CID_356023 | ||
| 0.219 | 0.03 | 0.219 | Ribosomal protein S6 kinase inhibitor | 0.124 0.086 CID_356023 | ||
| 0.201 | 0.015 | 0.201 | Polo-like kinase-4 inhibitor | 0.166 0.027 CID_356023 | ||
| 0.199 | 0.015 | 0.199 | 5 Hydroxytryptamine 3A agonist | 0.117 0.059 CID_356023 | ||
| 0.2 | 0.021 | 0.2 | Butyrylcholinesterase inhibitor | 0.12 0.047 CID_356023 | ||
| 0.249 | 0.071 | 0.249 | Antiamyloidogenic | 0.174 0.119 CID_356023 | ||
| 0.181 | 0.007 | 0.181 | 5 Hydroxytryptamine 3 antagonist | 0.059 0.036 CID_356023 | ||
| 0.195 | 0.021 | 0.195 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.172 0.04 CID_356023 | ||
| 0.225 | 0.053 | 0.225 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.122 0.114 CID_356023 | ||
| 0.216 | 0.047 | 0.216 | Lipocortins synthesis antagonist | |||
| 0.186 | 0.022 | 0.186 | MAP kinase kinase kinase inhibitor | 0.173 0.026 CID_356023 | ||
| 0.241 | 0.078 | 0.241 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.213 0.132 CID_356023 | ||
| 0.193 | 0.03 | 0.193 | Glycogen synthase kinase-3 beta inhibitor | 0.134 0.051 CID_356023 | ||
| 0.313 | 0.151 | 0.379 | 5 Hydroxytryptamine release inhibitor | 0.379 0.092 CID_356023 | CID_356023 | |
| 0.215 | 0.056 | 0.215 | LIM domain kinase 1 inhibitor | 0.164 0.085 CID_356023 | ||
| 0.207 | 0.048 | 0.207 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.148 0.079 CID_356023 | ||
| 0.197 | 0.038 | 0.197 | Activin receptor-like kinase 2 inhibitor | 0.119 0.098 CID_356023 | ||
| 0.203 | 0.045 | 0.203 | Cholinergic | |||
| 0.19 | 0.035 | 0.19 | GABA C receptor rho-2 antagonist | |||
| 0.229 | 0.082 | 0.229 | Dyrk kinase inhibitor | 0.152 0.134 CID_356023 | ||
| 0.181 | 0.039 | 0.181 | Acetylcholinesterase inhibitor | |||
| 0.22 | 0.081 | 0.22 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.152 0.129 CID_356023 | ||
| 0.145 | 0.009 | 0.145 | Benzodiazepine agonist | 0.088 0.033 CID_356023 | ||
| 0.205 | 0.069 | 0.205 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.173 0.102 CID_356023 | ||
| 0.152 | 0.02 | 0.152 | Telomerase inhibitor | 0.141 0.022 CID_356023 | ||
| 0.181 | 0.051 | 0.181 | Cyclin-dependent kinase 8 inhibitor | 0.165 0.065 CID_356023 | ||
| 0.144 | 0.014 | 0.144 | Interleukin 12 antagonist | 0.143 0.015 CID_356023 | ||
| 0.181 | 0.052 | 0.181 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.292 | 0.164 | 0.292 | Calcium channel L-type activator | 0.248 0.207 CID_356023 | ||
| 0.201 | 0.074 | 0.201 | Anesthetic general | |||
| 0.133 | 0.007 | 0.133 | Phosphodiesterase 3B inhibitor | 0.104 0.01 CID_356023 | ||
| 0.302 | 0.178 | 0.304 | MAP kinase 1 inhibitor | 0.304 0.175 CID_356023 | CID_356023 | |
| 0.165 | 0.043 | 0.165 | Topoisomerase II inhibitor | 0.122 0.065 CID_356023 | ||
| 0.193 | 0.071 | 0.193 | CDC-like kinase 4 inhibitor | 0.14 0.109 CID_356023 | ||
| 0.152 | 0.034 | 0.152 | GABA receptor agonist | 0.109 0.067 CID_356023 | ||
| 0.208 | 0.094 | 0.208 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.146 | 0.034 | 0.146 | Protein kinase C gamma inhibitor | 0.095 0.087 CID_356023 | ||
| 0.203 | 0.095 | 0.203 | RNA-directed DNA polymerase inhibitor | |||
| 0.12 | 0.012 | 0.12 | GABA A receptor antagonist | 0.047 0.045 CID_356023 | ||
| 0.122 | 0.015 | 0.122 | Phosphodiesterase III inhibitor | 0.094 0.025 CID_356023 | ||
| 0.142 | 0.036 | 0.142 | Nav1.1 sodium channel blocker | 0.104 0.062 CID_356023 | ||
| 0.155 | 0.052 | 0.155 | MAP kinase kinase 4 inhibitor | |||
| 0.136 | 0.033 | 0.136 | Protein kinase C mu inhibitor | 0.12 0.041 CID_356023 | ||
| 0.135 | 0.033 | 0.135 | Insulin receptor antagonist | 0.096 0.068 CID_356023 | ||
| 0.137 | 0.035 | 0.137 | Sphingosine 1-phosphate receptor 2 agonist | 0.106 0.086 CID_356023 | ||
| 0.131 | 0.03 | 0.131 | Phosphodiesterase 7B inhibitor | |||
| 0.11 | 0.011 | 0.11 | 5 Hydroxytryptamine 3 agonist | 0.056 0.055 CID_356023 | ||
| 0.126 | 0.029 | 0.126 | Protein kinase C zeta inhibitor | |||
| 0.166 | 0.07 | 0.166 | Peroxidase inhibitor | |||
| 0.11 | 0.014 | 0.11 | GABA receptor antagonist | |||
| 0.182 | 0.086 | 0.182 | Death-associated protein kinase 3 inhibitor | 0.158 0.11 CID_356023 | ||
| 0.183 | 0.089 | 0.183 | Clk dual-specificity kinase inhibitor | |||
| 0.124 | 0.037 | 0.124 | GABA C receptor rho-1 antagonist | |||
| 0.093 | 0.009 | 0.093 | Poly(ADP-ribose) polymerase inhibitor | 0.052 0.022 CID_356023 | ||
| 0.117 | 0.032 | 0.117 | mTOR complex 1 inhibitor | 0.111 0.04 CID_356023 | ||
| 0.145 | 0.062 | 0.145 | Phosphodiesterase inhibitor | |||
| 0.112 | 0.029 | 0.112 | Rho-associated kinase inhibitor | 0.097 0.036 CID_356023 | ||
| 0.169 | 0.087 | 0.169 | DNA methyltransferase I inhibitor | 0.164 0.091 CID_356023 | ||
| 0.114 | 0.034 | 0.114 | Toll-Like receptor 3 antagonist | |||
| 0.156 | 0.077 | 0.156 | Polo-like kinase-3 inhibitor | |||
| 0.149 | 0.07 | 0.149 | Protein kinase C nu inhibitor | |||
| 0.083 | 0.007 | 0.083 | Alpha 1L adrenoreceptor antagonist | 0.071 0.012 CID_356023 | ||
| 0.089 | 0.014 | 0.089 | AMPA receptor antagonist | |||
| 0.175 | 0.1 | 0.175 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.108 | 0.035 | 0.108 | Phosphodiesterase I inhibitor | |||
| 0.08 | 0.007 | 0.08 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.081 | 0.009 | 0.081 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.042 0.021 CID_356023 | ||
| 0.088 | 0.018 | 0.088 | Bruton tyrosine kinase inhibitor | 0.061 0.034 CID_356023 | ||
| 0.124 | 0.055 | 0.154 | Cyclin-dependent kinase 5 inhibitor | 0.154 0.038 CID_356023 | CID_356023 | |
| 0.119 | 0.053 | 0.119 | GABA C receptor antagonist | |||
| 0.08 | 0.016 | 0.085 | Factor IXa inhibitor | 0.085 0.014 CID_356023 | CID_356023 | |
| 0.068 | 0.004 | 0.072 | MAP3K5 inhibitor | 0.072 0.004 CID_356023 | CID_356023 | |
| 0.103 | 0.042 | 0.103 | Pim-3 kinase inhibitor | |||
| 0.067 | 0.006 | 0.067 | Nerve growth factor antagonist | 0.051 0.017 CID_356023 | ||
| 0.116 | 0.057 | 0.138 | Ferrochelatase inhibitor | 0.138 0.043 CID_356023 | CID_356023 | |
| 0.127 | 0.069 | 0.127 | Cyclin-dependent kinase inhibitor | 0.11 0.081 CID_356023 | ||
| 0.132 | 0.078 | 0.142 | Cytokine production inhibitor | 0.142 0.068 CID_356023 | CID_356023 | |
| 0.167 | 0.114 | 0.167 | Neurotrophic factor enhancer | |||
| 0.095 | 0.043 | 0.095 | GABA A receptor agonist | 0.083 0.058 CID_356023 | ||
| 0.081 | 0.029 | 0.081 | Protein kinase C beta inhibitor | |||
| 0.081 | 0.03 | 0.081 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.159 | 0.11 | 0.159 | DNA methylase inhibitor | 0.14 0.126 CID_356023 | ||
| 0.073 | 0.024 | 0.073 | Potassium channel (Ca-activated) blocker | |||
| 0.096 | 0.048 | 0.096 | Protein kinase A inhibitor | 0.075 0.065 CID_356023 | ||
| 0.149 | 0.102 | 0.149 | TRKC antagonist | |||
| 0.091 | 0.044 | 0.091 | Glutamate receptor agonist | |||
| 0.2 | 0.152 | 0.2 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.063 | 0.018 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.053 0.046 CID_356023 | ||
| 0.099 | 0.055 | 0.104 | Potassium channel (Voltage-sensitive) activator | 0.104 0.048 CID_356023 | CID_356023 | |
| 0.087 | 0.046 | 0.087 | Phosphodiesterase 3A inhibitor | |||
| 0.137 | 0.097 | 0.137 | Tyrosine kinase inhibitor | |||
| 0.104 | 0.065 | 0.119 | Mediator release inhibitor | 0.119 0.048 CID_356023 | CID_356023 | |
| 0.08 | 0.041 | 0.08 | Phosphodiesterase V inhibitor | |||
| 0.14 | 0.101 | 0.14 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.079 | 0.04 | 0.079 | Phosphodiesterase 5A inhibitor | |||
| 0.045 | 0.007 | 0.045 | Adenosine uptake inhibitor | 0.036 0.02 CID_356023 | ||
| 0.081 | 0.045 | 0.081 | MAP kinase kinase 7 inhibitor | |||
| 0.1 | 0.065 | 0.1 | Check point kinase 2 inhibitor | |||
| 0.105 | 0.074 | 0.105 | 5 Hydroxytryptamine antagonist | |||
| 0.053 | 0.022 | 0.053 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.065 | 0.035 | 0.065 | CDK4/cyclin D1 inhibitor | |||
| 0.058 | 0.03 | 0.059 | mTOR inhibitor | 0.059 0.029 CID_356023 | CID_356023 | |
| 0.159 | 0.132 | 0.159 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.067 | 0.039 | 0.067 | Glutamate (mGluR) agonist | |||
| 0.126 | 0.098 | 0.126 | Diuretic | |||
| 0.061 | 0.036 | 0.061 | Cyclin A1 inhibitor | 0.058 0.042 CID_356023 | ||
| 0.048 | 0.022 | 0.048 | Dihydrofolate reductase inhibitor | |||
| 0.061 | 0.036 | 0.061 | CDK4/cyclin D inhibitor | |||
| 0.038 | 0.015 | 0.038 | ATR kinase inhibitor | |||
| 0.067 | 0.044 | 0.067 | Cyclin-dependent kinase 4 inhibitor | 0.062 0.05 CID_356023 | ||
| 0.046 | 0.024 | 0.063 | CDK5/p25 inhibitor | 0.063 0.014 CID_356023 | CID_356023 | |
| 0.146 | 0.124 | 0.146 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.052 | 0.03 | 0.052 | Topoisomerase II beta inhibitor | 0.045 0.041 CID_356023 | ||
| 0.073 | 0.052 | 0.073 | Protein kinase B beta inhibitor | |||
| 0.051 | 0.03 | 0.051 | Histamine H4 receptor antagonist | |||
| 0.114 | 0.093 | 0.114 | Tyrosine-protein kinase receptor antagonist | |||
| 0.085 | 0.064 | 0.085 | CDK/cyclin complex inhibitor | |||
| 0.104 | 0.084 | 0.104 | TRKA antagonist | |||
| 0.083 | 0.062 | 0.083 | mTOR complex 2 inhibitor | |||
| 0.195 | 0.175 | 0.244 | Angiogenesis inhibitor | 0.244 0.128 CID_356023 | CID_356023 | |
| 0.081 | 0.061 | 0.081 | MAP-kinase-activated kinase inhibitor | |||
| 0.097 | 0.078 | 0.097 | Alpha 2b adrenoreceptor antagonist | |||
| 0.101 | 0.082 | 0.101 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.053 | 0.034 | 0.055 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.055 0.033 CID_356023 | CID_356023 | |
| 0.085 | 0.066 | 0.087 | Bromodomain-containing protein 2 inhibitor | 0.087 0.061 CID_356023 | CID_356023 | |
| 0.06 | 0.041 | 0.065 | Phosphatidylinositol kinase inhibitor | 0.065 0.037 CID_356023 | CID_356023 | |
| 0.044 | 0.026 | 0.044 | DNA gyrase subunit A inhibitor | |||
| 0.082 | 0.064 | 0.082 | Insulin growth factor antagonist | |||
| 0.073 | 0.056 | 0.073 | Phosphodiesterase VI inhibitor | |||
| 0.111 | 0.094 | 0.111 | DNA repair enzyme inhibitor | |||
| 0.072 | 0.055 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.09 | 0.075 | 0.09 | Alpha 2c adrenoreceptor antagonist | |||
| 0.105 | 0.09 | 0.105 | Glutamate receptor antagonist | |||
| 0.192 | 0.177 | 0.192 | Transcription factor NF kappa B inhibitor | |||
| 0.152 | 0.138 | 0.152 | Aldehyde oxidase inhibitor | |||
| 0.109 | 0.095 | 0.109 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.048 | 0.034 | 0.048 | Cytokine production stimulant | |||
| 0.083 | 0.069 | 0.083 | NADH dehydrogenase inhibitor | |||
| 0.046 | 0.033 | 0.046 | Thymidylate synthase inhibitor | |||
| 0.066 | 0.053 | 0.066 | Syk tyrosine kinase inhibitor | |||
| 0.077 | 0.065 | 0.077 | Insulin like growth factor 1 antagonist | |||
| 0.069 | 0.057 | 0.069 | Glycine receptor agonist | |||
| 0.104 | 0.093 | 0.104 | RET inhibitor | |||
| 0.07 | 0.06 | 0.07 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.069 | 0.059 | 0.069 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.032 | 0.022 | 0.032 | Protein kinase C beta II inhibitor | |||
| 0.063 | 0.053 | 0.063 | CDC7 inhibitor | |||
| 0.074 | 0.064 | 0.074 | Platelet growth factor antagonist | |||
| 0.081 | 0.071 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.041 | 0.031 | 0.041 | Guanylate cyclase inhibitor | |||
| 0.02 | 0.011 | 0.02 | Follicle-stimulating hormone antagonist | 0.019 0.017 CID_356023 | ||
| 0.06 | 0.051 | 0.06 | Prolactin release inhibitor | |||
| 0.069 | 0.059 | 0.072 | Protein kinase B gamma inhibitor | 0.072 0.055 CID_356023 | CID_356023 | |
| 0.059 | 0.05 | 0.059 | I kappa B kinase 2 inhibitor | |||
| 0.095 | 0.087 | 0.095 | Interleukin 1b antagonist | |||
| 0.057 | 0.049 | 0.057 | NMDA 2C receptor antagonist | |||
| 0.062 | 0.054 | 0.062 | Cyclin B3 inhibitor | |||
| 0.102 | 0.094 | 0.102 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.087 | 0.08 | 0.087 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.077 | 0.07 | 0.077 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.071 CID_356023 | ||
| 0.057 | 0.051 | 0.057 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.088 | 0.082 | 0.088 | Phosphodiesterase 6D inhibitor | |||
| 0.088 | 0.082 | 0.088 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.024 | 0.018 | 0.024 | Calcitonin gene-related peptide antagonist | |||
| 0.036 | 0.031 | 0.036 | Vascular adhesion protein 1 inhibitor | |||
| 0.032 | 0.028 | 0.032 | Tubulin agonist | |||
| 0.05 | 0.046 | 0.05 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.027 | 0.023 | 0.027 | AMPA 3 receptor antagonist | |||
| 0.073 | 0.069 | 0.073 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.054 | 0.051 | 0.054 | Acetylcholine M5 receptor antagonist | |||
| 0.062 | 0.059 | 0.062 | Protein kinase B alpha inhibitor | |||
| 0.027 | 0.025 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.065 | 0.063 | 0.065 | Rho-associated kinase I inhibitor | |||
| 0.081 | 0.08 | 0.081 | Pim-1 kinase inhibitor | |||
| 0.02 | 0.018 | 0.02 | Follicle-stimulating hormone agonist | |||
| 0.052 | 0.051 | 0.052 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.032 | 0.032 | 0.039 | Delayed rectifier potassium channel activator | 0.039 0.023 CID_356023 | CID_356023 | |
| 0.032 | 0.032 | 0.039 | Potassium channel KCNQ activator | 0.039 0.023 CID_356023 | CID_356023 | |
| 0.041 | 0.053 | 0.046 | Benzodiazepine antagonist | 0.046 0.035 CID_356023 | CID_356023 | |
| 0.057 | 0.07 | 0.064 | Polo-like kinase-2 inhibitor | 0.064 0.06 CID_356023 | CID_356023 | |
| 0.037 | 0.06 | 0.046 | Phosphatidylinositol 3-kinase beta inhibitor | 0.046 0.039 CID_356023 | CID_356023 | |
| 0.012 | 0.034 | 0.018 | Apolipoprotein B inhibitor | 0.018 0.016 CID_356023 | CID_356023 | |
| 0.13 | 0.161 | 0.212 | Death-associated protein kinase 2 inhibitor | 0.212 0.027 CID_356023 | CID_356023 | |
| 0.103 | 0.139 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.059 CID_356023 | CID_356023 | |
| 0.051 | 0.089 | 0.069 | ErbB-4 antagonist | 0.069 0.061 CID_356023 | CID_356023 | |
| 0.028 | 0.08 | 0.084 | Melanin-concentrating hormone receptor 1 antagonist | 0.084 0.018 CID_356023 | CID_356023 | |
| 0.157 | 0.212 | 0.207 | Neuropeptide Y2 antagonist | 0.207 0.107 CID_356023 | CID_356023 | |
| 0.141 | 0.204 | 0.194 | 5 Hydroxytryptamine 1E antagonist | 0.194 0.137 CID_356023 | CID_356023 | |
| 0.078 | 0.142 | 0.096 | CDC-like kinase 3 inhibitor | 0.096 0.089 CID_356023 | CID_356023 | |
| 0.054 | 0.118 | 0.084 | Glycine receptor antagonist | 0.084 0.051 CID_356023 | CID_356023 | |
| 0.15 | 0.218 | 0.172 | 5 Hydroxytryptamine 3E antagonist | 0.172 0.13 CID_356023 | CID_356023 | |
| 0.033 | 0.109 | 0.052 | Heparanase inhibitor | 0.052 0.04 CID_356023 | CID_356023 | |
| 0.093 | 0.178 | 0.128 | Aurora-C kinase inhibitor | 0.128 0.088 CID_356023 | CID_356023 | |
| 0.212 | 0.303 | 0.305 | Caspase 9 stimulant | 0.305 0.189 CID_356023 | CID_356023 | |
| 0.101 | 0.198 | 0.131 | Death-associated protein kinase 1 inhibitor | 0.131 0.078 CID_356023 | CID_356023 | |
| 0.151 | 0.268 | 0.275 | DNA polymerase beta inhibitor | 0.275 0.178 CID_356023 | CID_356023 | |
| 0.113 | 0.232 | 0.164 | Cyclin-dependent kinase 3 inhibitor | 0.164 0.068 CID_356023 | CID_356023 | |
| 0.061 | 0.194 | 0.128 | Alpha-N-acetylglucosaminidase inhibitor | 0.128 0.07 CID_356023 | CID_356023 | |
| 0.052 | 0.22 | 0.102 | Caspase 3 inhibitor | 0.102 0.088 CID_356023 | CID_356023 | |
| 0.1 | 0.295 | 0.21 | Thyroid hormone beta antagonist | 0.21 0.146 CID_356023 | CID_356023 | |
| 0.093 | 0.31 | 0.198 | Thyroid hormone antagonist | 0.198 0.163 CID_356023 | CID_356023 | |
| 0.057 | 0.275 | 0.114 | CDK3/cyclin E inhibitor | 0.114 0.064 CID_356023 | CID_356023 | |
| 0.08 | 0.353 | 0.212 | Calpain 2 inhibitor | 0.212 0.177 CID_356023 | CID_356023 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |